glp-1 receptor antagonist Complementary Yet Distinct Roles of Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction Unlocking the multifaceted roles of

Factor SA, Wolski K, Togasaki DM, Huyck S, Cantillon M, Ho TW, et al

Your medication ships to your door with ongoing check-ins and dose adjustments as needed

GLP-1 receptor knockout and GIP receptor knockout mice for mechanism delineation Receptor binding studies: Human, mouse, and rat receptor-expressing cell lines In vitro systems: Primary hepatocytes for gluconeogenesis studies

In 2025, our product investments meaningfully increased engagement, and engagement translates into better results at every stage of the journey

Currently, there are no approved targeted therapies for LVEF-preserved heart failure associated with obesity

GLP-1 medications work through multiple mechanisms: 1